Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Emery

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
Trials|March 20, 2026
Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trialJennifer G McIntosh, Belinda Goodwin, Driss Ait Ouakrim, et al.
The Medical Journal of Australia|May 30, 2021
Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare StandardsEva Segelov, Christine Carrington, Sanchia Aranda, et al.
The Medical Journal of Australia|July 28, 2025
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summaryLeon A Adams, William W Kemp, Kate R Muller, et al.
Gut|April 5, 2023
Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasiaFrancis K L Chan, Martin C S Wong, Andrew T Chan, et al.
Trials|July 27, 2018
The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trialJennifer G Walker, Finlay Macrae, Ingrid Winship, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 3, 2023
The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screeningJon D Emery, Mark A Jenkins, Sibel Saya, et al.
Trials|November 14, 2023
SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening ProgramJennifer G McIntosh, Jon D Emery, Anna Wood, et al.
Implementation Science : IS|March 24, 2026
Ready to screen implementation trial protocol: a cluster randomized implementation trial comparing a bundled implementation strategy versus a simple implementation strategy to improve intention to screen in the Australian National Lung Cancer Screening ProgramDzenana Kartal, Christine Paul, Georgia Bartlett, et al.
Familial Cancer|June 19, 2019
Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family historyMark A Jenkins, Aung K Win, James G Dowty, et al.
JAMA Dermatology|March 11, 2026
Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance TrialEllie Medcalf, Deonna M Ackermann, Jake T W Williams, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Trials|March 20, 2026
Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trialJennifer G McIntosh, Belinda Goodwin, Driss Ait Ouakrim, et al.
The Medical Journal of Australia|May 30, 2021
Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare StandardsEva Segelov, Christine Carrington, Sanchia Aranda, et al.
The Medical Journal of Australia|July 28, 2025
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summaryLeon A Adams, William W Kemp, Kate R Muller, et al.
Gut|April 5, 2023
Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasiaFrancis K L Chan, Martin C S Wong, Andrew T Chan, et al.
Trials|July 27, 2018
The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trialJennifer G Walker, Finlay Macrae, Ingrid Winship, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 3, 2023
The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screeningJon D Emery, Mark A Jenkins, Sibel Saya, et al.
Trials|November 14, 2023
SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening ProgramJennifer G McIntosh, Jon D Emery, Anna Wood, et al.
Implementation Science : IS|March 24, 2026
Ready to screen implementation trial protocol: a cluster randomized implementation trial comparing a bundled implementation strategy versus a simple implementation strategy to improve intention to screen in the Australian National Lung Cancer Screening ProgramDzenana Kartal, Christine Paul, Georgia Bartlett, et al.
Familial Cancer|June 19, 2019
Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family historyMark A Jenkins, Aung K Win, James G Dowty, et al.
JAMA Dermatology|March 11, 2026
Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance TrialEllie Medcalf, Deonna M Ackermann, Jake T W Williams, et al.
Pageof 26